United States:
FDA Issues Emergency Use Authorization For MERS-Cov Detection Device
29 September 2015
Jones Day
To print this article, all you need is to be registered or login on Mondaq.com.
In the September 1, 2015, Federal Register,
FDA announced the issuance of an EUA for an in vitro diagnostic
device for detection of Middle East Respiratory Syndrome
Coronavirus (MERS-CoV). FDA issued this authorization under the
FDCA, as requested by altona Diagnostics GmbH.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
